Ottobock: The Future Star on the Stock Market for Human Bionics? Goldman Sachs Sees 50% Price Potential as Margins Are Expected to Rise to 30%!
Reading Time: 3 minutes
The future of mobility is not only decided on the roads but directly on the human body. Ottobock positions itself today as the world's leading "Human Bionics Company" and backs this claim with impressive market dominance: The company is the global number one in human bionics, a market that encompasses not only classical prosthetics but also technologically advanced neuro-orthotics and digital solutions. With an addressable market volume of approximately €14 billion in 2025, expected to grow to around €19 billion by 2029, Ottobock operates in...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
